News November 17, 2017 - Diazon Pharmaceutical’s anti-cancer agent DZ-2384 mechanism for high activity and low neurotoxicity published by McGill researchers in Science Translational Medicine Read More November 15, 2017 - DalCor Pharmaceuticals Appoints Dr. Fouzia Laghrissi-Thode to the Board of Directors Read More November 8, 2017 - Lineagen, Inc. Named to MountainWest Capital Network’s 2017 Utah 100 Read More October 4, 2017 - ViaCyte to Present at Upcoming Investor & Partnering Events in October Read More October 2, 2017 - Ellis Opens Expanded Pharmacy with Automated Dispenser Read More September 28, 2017 - ViaCyte Awarded New CIRM Grant to Support Clinical Trial of PEC-Direct Product Candidate for High Risk Type 1 Diabetes Read More September 21, 2017 - ViaCyte Selected as a Finalist for CONNECT’s 30th Annual Most Innovative New Product Awards Read More September 14, 2017 - CONNECT Announces Finalists for 2017 Most Innovative New Products Awards Read More September 11, 2017 - SpecificiT Raises Seed Financing Read More September 7, 2017 - ViaCyte to Present at Upcoming Scientific Meetings on Diabetes Research Read More